Guangdong Transtek Medical Electronics Co., Ltd (300562.SZ)
CNY 16.27
(-6.92%)
CNY 16.27
(-6.92%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 532.34 Million CNY | -2.94% |
| 2022 | 548.46 Million CNY | -26.59% |
| 2021 | 747.09 Million CNY | 2.62% |
| 2020 | 728.04 Million CNY | 76.03% |
| 2019 | 413.58 Million CNY | 19.35% |
| 2018 | 346.54 Million CNY | 44.02% |
| 2017 | 240.62 Million CNY | 54.3% |
| 2016 | 155.94 Million CNY | 33.18% |
| 2015 | 117.09 Million CNY | 13.48% |
| 2014 | 103.18 Million CNY | 6.34% |
| 2013 | 97.03 Million CNY | 42.15% |
| 2012 | 68.26 Million CNY | 27.38% |
| 2011 | 53.58 Million CNY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 514.22 Million CNY | -3.4% |
| 2024 Q3 | 538.22 Million CNY | -3.96% |
| 2024 Q2 | 560.42 Million CNY | 8.98% |
| 2023 FY | 532.34 Million CNY | -2.94% |
| 2023 Q3 | 591.43 Million CNY | 21.01% |
| 2023 Q2 | 488.72 Million CNY | 5.06% |
| 2023 Q4 | 532.34 Million CNY | -9.99% |
| 2023 Q1 | 465.18 Million CNY | -15.18% |
| 2022 FY | 548.46 Million CNY | -26.59% |
| 2022 Q4 | 548.46 Million CNY | 5.77% |
| 2022 Q1 | 581.84 Million CNY | -22.12% |
| 2022 Q2 | 482.73 Million CNY | -17.03% |
| 2022 Q3 | 518.52 Million CNY | 7.41% |
| 2021 Q3 | 804.9 Million CNY | 5.79% |
| 2021 FY | 747.09 Million CNY | 2.62% |
| 2021 Q2 | 760.85 Million CNY | 11.47% |
| 2021 Q4 | 747.09 Million CNY | -7.18% |
| 2021 Q1 | 682.59 Million CNY | -6.24% |
| 2020 Q3 | 585.78 Million CNY | 40.64% |
| 2020 Q2 | 416.5 Million CNY | 17.07% |
| 2020 Q1 | 355.76 Million CNY | -13.98% |
| 2020 FY | 728.04 Million CNY | 76.03% |
| 2020 Q4 | 728.04 Million CNY | 24.29% |
| 2019 Q1 | 312.5 Million CNY | -9.82% |
| 2019 FY | 413.58 Million CNY | 19.35% |
| 2019 Q2 | 289.6 Million CNY | -7.33% |
| 2019 Q4 | 413.58 Million CNY | 9.96% |
| 2019 Q3 | 376.13 Million CNY | 29.88% |
| 2018 Q4 | 346.54 Million CNY | 21.0% |
| 2018 Q2 | 268.9 Million CNY | 1.85% |
| 2018 Q1 | 264.01 Million CNY | 9.72% |
| 2018 FY | 346.54 Million CNY | 44.02% |
| 2018 Q3 | 286.39 Million CNY | 6.5% |
| 2017 Q1 | 139.29 Million CNY | -10.68% |
| 2017 FY | 240.62 Million CNY | 54.3% |
| 2017 Q3 | 207.25 Million CNY | 2.02% |
| 2017 Q2 | 203.15 Million CNY | 45.85% |
| 2017 Q4 | 240.62 Million CNY | 16.1% |
| 2016 Q4 | 155.94 Million CNY | -63.1% |
| 2016 Q1 | - CNY | -100.0% |
| 2016 Q3 | 422.64 Million CNY | 206.79% |
| 2016 Q2 | 137.76 Million CNY | 0.0% |
| 2016 FY | 155.94 Million CNY | 33.18% |
| 2015 FY | 117.09 Million CNY | 13.48% |
| 2015 Q4 | 117.09 Million CNY | 0.0% |
| 2015 Q1 | 106.6 Million CNY | 3.31% |
| 2014 Q1 | 80.72 Million CNY | 0.0% |
| 2014 Q3 | 102.7 Million CNY | 27.14% |
| 2014 FY | 103.18 Million CNY | 6.34% |
| 2014 Q4 | 103.18 Million CNY | 0.47% |
| 2014 Q2 | 80.78 Million CNY | 0.07% |
| 2013 FY | 97.03 Million CNY | 42.15% |
| 2012 FY | 68.26 Million CNY | 27.38% |
| 2011 FY | 53.58 Million CNY | 0.0% |